Siemens co-develops Alzheimer's blood test

A group from Siemens Healthcare ($SI) and Saarland University in Germany says they've developed a blood test that could identify patients with Alzheimer's disease and rule out the affliction in others. Their test focused on a panel of 12 miRNAs, which appeared in different levels in Alzheimer's patients versus healthy controls. Subsequently, the concept worked again in a larger patient sample and surpassed the 90% level in accuracy, sensitivity and specificity. Details are published in the journal Genome Biology. Item | Journal abstract

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.